Stanford University
Showing 2,281-2,300 of 7,825 Results
-
Emily Geminder
Lecturer
BioEmily Geminder is the author of Dead Girls and Other Stories, winner of the Dzanc Books Short Story Prize. Her stories, poems, and essays have appeared in American Short Fiction, Conjunctions, Kenyon Review, New England Review, Tin House, and elsewhere. A former Stegner Fellow, she’s also received fellowships from Yaddo, the Center for Feminist Research, and others. She currently teaches creative writing at Stanford University.
-
Michael Genesereth
Associate Professor of Computer Science
BioGenesereth is most known for his work on Computational Logic and applications of that work in Enterprise Management, Computational Law, and General Game Playing. He is one of the founders of Teknowledge, CommerceNet, Mergent Systems, and Symbium. Genesereth is the director of the Logic Group at Stanford and the founder and research director of CodeX - the Stanford Center for Legal Informatics.
-
Linda N. Geng, MD, PhD
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy scholarly focus is on puzzling and complex conditions. Our work aims to improve patients' diagnostic journeys, characterize poorly understood diseases, discover biological mechanisms, find treatments, improve care models, and reach communities in need.
With the COVID pandemic, the puzzling and complex illness of Long COVID or post-acute COVID-19 syndrome (PACS) emerged. Together with a multidisciplinary group of physicians and researchers, we launched a program here at Stanford to advance the care and understanding of Long COVID. Our goal is to better understand the natural history, clinical symptomatology, immunological response, risk factors, and subtypes of Long COVID. We are also actively assessing treatment strategies for Long COVID and developing care pathways and tools for clinicians to help their patients with this and other related infection-associated chronic illnesses. -
Grace Gengoux, PhD, BCBA-D
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsDr. Grace Gengoux is Director of the Autism Intervention Clinic and leads an autism intervention research program focused on developing and evaluating promising behavioral and developmental treatments for Autism Spectrum Disorder (ASD).
Dr. Gengoux is also Associate Chair for Faculty Engagement & Well-being and Department Well-being Director in the Department of Psychiatry and Behavioral Sciences, leading the department's Standing Well-being Advisory Committee. -
Mark Genovese
James W. Raitt M.D. Professor, Emeritus
Current Research and Scholarly InterestsClinical trials and interventions in the rheumatic diseases including Rheumatoid Arthritis,Systemic Lupus Erythematosus, Systemic Sclerosis, Osteoarthritis.
-
Michael Gensheimer
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
Current Research and Scholarly InterestsIn addition to my clinical research in head and neck and lung cancer, I work on the application of computer science and machine learning to cancer research. I develop tools for analyzing large datasets to improve outcomes and safety of cancer treatment. I developed a machine learning prognostic model using data from around 13,000 patients with metastatic cancer which performs better than traditional models and physicians [PubMed ID 33313792]. We recently completed a prospective randomized study in thousands of patients in which the model was used to help improve advance care planning conversations.
I also work on the methods underpinning observational and predictive modeling research. My open source nnet-survival software that allows use of neural networks for survival modeling has been used by researchers internationally. In collaboration with the Stanford Research Informatics Center, I examined how electronic medical record (EMR) survival outcome data compares to gold-standard data from a cancer registry [PubMed ID 35802836]. The EMR data captured less than 50% of deaths, a finding that affects many studies being published that use EMR outcomes data. -
Andrew Gentles
Associate Professor (Research) of Pathology, of Medicine (Computational Medicine) and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsComputational systems biology
-
Paul George, MD, PhD
Associate Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDEVELOPMENT OF STROKE RECOVERY THERAPEUTICS:
Stroke is devastating to patients and their caregivers. We currently are investigating 3 neural repair approaches. The first focuses on developing a stroke recovery therapeutic based on an essential repair pathway and how it alters the immune response following stroke. The second utilizes implantable, conductive polymer devices to electrically manipulate the recovering nervous system to improve recovery and identify novel therapeutic targets. The final approach works to optimize stem cell therapeutics to enhance their ability to treat patients who have suffered from neural injury.
CONDUCTIVE BIOPOLYMER SYSTEMS FOR NEURAL RECOVERY AND STEM CELL MODULATION:
The George lab develops biomaterials to improve neural recovery in the peripheral and central nervous systems. By controlled release of drugs and molecules through biomaterials we can study the temporal effect of these neurotrophic factors on neural recovery and engineer drug delivery systems to enhance regenerative effects. By identifying the critical mechanisms for neural recovery, we are able to develop polymeric technologies for clinical translation in nerve regeneration. Recent work utilizes these novel conductive polymers to differentiate stem cells for therapeutic and drug discovery applications.
APPLYING ENGINEERING TECHNIQUES TO DETERMINE BIOMARKERS FOR STROKE DIAGNOSTICS:
The ability to create diagnostic assays and techniques enables us to understand biological systems more completely and improve clinical management. Previous work utilized mass spectroscopy proteomics to find a simple serum biomarker for TIAs (a warning sign of stroke). Our study discovered a novel candidate marker, platelet basic protein. Current studies are underway to identify further candidate biomarkers using transcriptome analysis. More accurate diagnosis will allow for aggressive therapies to prevent subsequent strokes. -
Marios Georgiadis
Instructor, Radiology
BioMarios is an Instructor of Neuroimaging in the Department of Radiology.
His research focuses mainly on studying brain microstructure using cutting edge imaging (advanced X-ray, MRI, optical, and spatial biology approaches), with a particular focus on Alzheimer's disease hippocampi, neurodegeneration, and a special interest in myelin and iron.
He is also actively involved in projects related to imaging and modeling brain trauma, exosome signatures of neurodegeneration, and imaging the brain using advanced forms of electron and light microscopy.
His current research is being supported by NIH, the Alzheimer's Association, the American Society of Neuroradiology, the National Alzheimer's Coordinating Center (NACC), and the Stanford ADRC.
Marios is a mechanical engineer by training (School of Mechanical Engineering, National Technical University of Athens, Greece). His thesis "Closed-loop force control of a haptic surgical simulator", was performed in the Control Systems Lab of Prof. Evangelos Papadopoulos.
In 2011 he obtained his MSc in Biomedical Engineering from ETH Zurich (Swiss Federal Institute of Technology). He performed his thesis in IBM Research on "Advanced pathology using the Microfluidic Probe", under Emmanuel Delamarche and Govind Kaigala, and was awarded the ETH medal for this work.
He completed his PhD in Bone Biomechanics in the lab of Prof. Ralph Muller in ETH Zurich, where he developed X-ray scattering-based methods to investigate bone microstructure in 3D, research that earned him the 2nd Student Award from the European Society for Biomechanics in 2015.
In 2016 he started using imaging methods to study brain microstructure, in the lab of Prof. Markus Rudin, in the Institute for Biomedical Engineering of ETH Zurich. There, he combined X-ray scattering with DTI, histology and CLARITY for studying rodent brain.
In 2017 he joined the MRI Biophysics group of Profs. Els Fieremans and Dmitry Novikov in New York University School of Medicine, to study human and mouse brain microstructure using X-ray scattering and diffusion MRI.
He is in the Translational Neuroimaging lab, headed by Dr Michael Zeineh, since 2019.
His research on myelin in mouse and human brain using X-ray scattering has been supported twice by the Swiss National Science Foundation. -
Daniel Aaron Gerber, MD
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioDr. Gerber is a critical care cardiologist and medical director of Stanford's cardiac ICU. He has dual subspecialty training in cardiovascular and critical care medicine and additional board certification in echocardiography. He completed his residency in internal medicine, fellowship in cardiovascular medicine, and an additional fellowship in critical care medicine at Stanford University and joined as faculty in 2021 as a Clinical Assistant Professor in the Department of Medicine’s Division of Cardiovascular Medicine.
Dr. Gerber manages the full spectrum of heart and vascular conditions with a focus on critically ill patients with life-threatening cardiovascular disease. He is active in medical education, teaching introductory echocardiography to Stanford medical students and residents, co-directing the Stanford Critical Care Medicine Critical Care Ultrasound Program, and lecturing nationally on critical care echocardiography and point-of-care ultrasonography at the Society of Critical Care Medicine’s annual congress. Finally, Dr. Gerber’s research interests focus on optimizing cardiac intensive care, including working with the Critical Care Cardiology Trials Network (CCCTN) - a national network of tertiary cardiac ICUs coordinated by the TIMI Study Group - and studying acute mechanical circulatory support techniques to improve patient outcomes and care processes. -
J. Christian Gerdes
Professor of Mechanical Engineering, Emeritus
BioChris Gerdes is a Professor Emeritus of Mechanical Engineering at Stanford University. His laboratory studies how cars move, how humans drive cars and how to design future cars that work cooperatively with the driver or drive themselves. Vehicles in the lab include X1, a student-built electric, steer-by-wire test vehicle; Takumi, a modified Toyota Supra capable of autonomous drifting in tandem with another car; and Marty, the electrified, automated, drifting DeLorean. Chris' interests in vehicle safety extend to ethics and government policy, having helped to develop the US Federal Automated Vehicle Policy while serving as the first Chief Innovation Officer of the US Department of Transportation.
-
Yael Gernez
Clinical Associate Professor, Pediatrics - Immunology
BioMy clinic focuses on solving the molecular puzzles that underlie rare allergic and immunologic diseases to shed light on fundamental principles governing allergy, inflammation and immune system defects. My goal is to find better and safer therapies for my patients with rare diseases that include autoinflammation, autoimmunity and primary immune deficiency. It is important to highlight that every patient requires individualized therapeutic approaches based on their underlying genetic problem and the types and severity of their clinical manifestations. For some patients, a hematopoietic stem cell transplant (HSCT) is curative while for others, a targeted drug therapy, such as a biologic or small molecule agent, is most suitable. In some cases, a truly novel therapy may be required, .e.g., anti-sense oligonucleotide therapy to suppress aberrant gene splicing or adoptive cellular therapy. My passion is to provide the best personalized therapy for our patients with allergy and immunology diseases. This often requires performing very specialized functional assays and in some cases in enlisting laboratories with specific expertise or interest in particular genetic disorders.
